SUZ12 and endometrioid stromal sarcoma: Because of this and based on the outcome of our study regarding the involvement of p38 in JAZF1-SUZ12 fusion protein level regulation, we posit that p38 inhibition may ameliorate symptoms associated with PRC2 complex dysfunction observed in endometrial stromal sarcoma (ESS).